Endometrial (uterine) cancer screening

               Screening for endometrial cancer (uterine cancer) is only recommended for women at high risk.

               The increased risk does not mean that you will definitely get endometrial cancer. However, you need to start undergoing regular examinations for the prevention and early detection of tumor diseases. With early detection of cancer, the chances of successful treatment are significantly high.

Risk factors:

• Excessive growth of endometrial cells (endometrial hyperplasia). Hyperplasia is not yet cancer, but sometimes it can become malignant. Prolonged and heavy periods, spotting between periods, and bleeding after menopause are common signs of this condition. Endometrial hyperplasia is a common condition in women after 40 years.
• Obesity. Obese women have a greater risk of developing endometrial cancer.
• Complicated reproductive and menstrual history: women who have never had children, or menstruation began before the age of 12, or continued after 55 years.
• Taking hormonal contraceptives based only on estrogen, without a history of progesterone addition.
• History of tamoxifen (for the treatment of breast cancer).
• Complicated family history: women whose mothers, sisters or daughters have had endometrial cancer are at risk, as well as women with a hereditary form of colon cancer (Lynch syndrome).
• Postmenopause.

Women who include at least one of these risk factors should be regularly screened for endometrial cancer:

• Transvaginal ultrasound every 6-12 months.

               Along with regular examinations, you need to monitor your condition. Symptoms such as irregular bleeding or discharge should be reported to your doctor immediately.

               For women who have undergone endometrial cancer, an individual plan of examination for recurrence is required, drawn up by the attending physician.

               At the NROC, you can undergo high-quality diagnostics, perform a "revision of glass preparations" to obtain a "second opinion" about the type of tumor cells, and, if necessary, immediately begin and receive qualified treatment.